Aurora Cannabis (TSE:ACB) Hits New 52-Week Low – Time to Sell?

Aurora Cannabis Inc. (TSE:ACB) shares reached a new 52-week low during trading on Monday . The stock traded as low as C$3.74 and last traded at C$3.76, with a volume of 313521 shares. The stock had previously closed at C$3.86.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ACB shares. TD reduced their price target on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Canaccord Genuity Group cut their target price on shares of Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of C$7.17.

Aurora Cannabis Trading Down 1.1%

The company has a debt-to-equity ratio of 4.66, a quick ratio of 2.48 and a current ratio of 5.94. The company’s 50-day moving average price is C$4.40 and its 200-day moving average price is C$4.89. The firm has a market capitalization of C$232.90 million, a PE ratio of -1.76 and a beta of 0.27.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Thursday, June 11th. The company reported C($0.99) EPS for the quarter. Aurora Cannabis had a negative net margin of 12.13% and a negative return on equity of 7.25%. The business had revenue of C$38.01 million during the quarter. On average, sell-side analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.